Myeloma Paper of the Day, September 15th, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, September 15th, suggested by Robert Orlowski / A. Huart, A. Lazareth, A. Perrot, B. De Renzis, B. Lioure, C. Louni, dialysis, F.
Myeloma Paper of the Day, September 15th, suggested by Robert Orlowski / A. Huart, A. Lazareth, A. Perrot, B. De Renzis, B. Lioure, C. Louni, dialysis, F.
Adding inotuzumab ozogamicin (InO) to hyper-CVAD and blinatumomab may improve outcomes in newly diagnosed Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (B-ALL). Patients w…
Listen now | A conversation with Margaret McCartney
Key Points. No significant association was identified between PFT metrics and CRS grade >2 or ICANS grade >2Lack of correlation between PFT metrics a
The new price cap, part of the Inflation Reduction Act, will apply to all prescription drugs covered by Medicare.
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy shows promising efficacy and manageable toxicity and could be a potential treatment option for patients with brain…
Chronic myelomonocytic leukemia (CMML) is an aggressive clonal stem cell disorder categorized amongst myelodysplastic/myeloproliferative (MDS/MPN) overlap neoplasms. While sharing features with both MDS and MPN,…
Individuals ineligible for ADHD medication trials face higher risks of adverse outcomes. This study provides the first empirical evidence for the limited generalisability of ADHD…
Background Standardised Diagnostic Assessment tools, such as the Development and Well-Being Assessment (DAWBA), may aid detection and diagnosis of emotional disorders but there is limited…
Background Identifying clusters of multiple long-term conditions (MLTCs), also known as multimorbidity, and their associated burden may facilitate the development of effective and cost-effective targeted…
To truly learn from this case, we must accept that the crimes of Dominique Pelicot were not committed in a vacuum.